Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Ultragenyx Inks a Partner-to-Buy Deal with GeneTx to Develop Treatment for Rare Genetic Syndrome

Novato, California-based Ultragenyx and Downers Grove, Illinois-based GeneTx Biotherapeutics are partnering to advance a therapy for a rare neurogenetic disorder, Angelman syndrome. Ultragenyx also has the option to acquire GeneTx.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom